Harender Kumar | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Harender Kumar | Neuroscience | Best Researcher AwardΒ πŸ†

Research Scholar at Panjab University Chandigarh, India.

Harender Kumar, a Research Scholar at Panjab University, Chandigarh, specializes in behavioral neuroscience. His work primarily focuses on investigating the relationship between diet, gut health, and stress resilience using zebrafish as a model organism. Kumar has published three notable journal articles in SCI/Scopus-indexed journals, with impactful contributions to neuroscience and chemistry. His research demonstrates a promising ability to bridge fundamental science with potential real-world applications.

Profile

Scopus

Education πŸŽ“:

Harender Kumar is pursuing his Ph.D. at Panjab University, Chandigarh, focusing on behavioral neuroscience. His academic journey reflects his dedication to understanding the complex interplay between biological systems and mental health. Harender’s educational background has provided a strong foundation in neuroscience, biology, and chemistry, enabling him to engage in cutting-edge research. At Panjab University, he has honed his expertise in experimental design, data analysis, and interdisciplinary collaboration, contributing significantly to his academic and professional growth. Through his education, Harender has developed a keen interest in the gut-brain axis, stress mechanisms, and the therapeutic potential of dietary interventions, preparing him for a promising career in research and innovation.

Work Experience πŸ’Ό:

Harender Kumar has significant experience in behavioral neuroscience research, with a focus on gut-brain interactions and stress resilience. As a Research Scholar at Panjab University, he has conducted innovative studies using zebrafish models, exploring how dietary components influence mental health. Harender has collaborated with experts in chemistry to address diverse scientific challenges, such as detecting chemical agents and understanding synaptic remodeling. His hands-on expertise includes experimental planning, animal model studies, and data interpretation, which have resulted in publications in SCI/Scopus-indexed journals. Harender’s multidisciplinary experience reflects his ability to navigate complex scientific questions and contribute meaningfully to neuroscience and beyond.

Awards and Honors

Though specific awards and honors are not mentioned in the profile, Harender Kumar’s accomplishments in publishing high-quality research in reputable journals demonstrate academic recognition. His work has contributed to advancing behavioral neuroscience and interdisciplinary science. Securing awards such as research grants, best paper accolades, or conference presentations would further highlight his achievements and scholarly impact.

Research Interests:

Harender Kumar’s research centers on behavioral neuroscience, with an emphasis on understanding the gut-brain axis and its role in stress resilience. Using zebrafish as a model organism, he investigates the link between dietary factors and mental well-being, providing insights into potential therapeutic strategies. His multidisciplinary work integrates neuroscience, physiology, and chemistry, addressing critical issues such as synaptic remodeling and the stress-resilient effects of dietary interventions. Harender’s innovative approach has contributed to a deeper understanding of mental health challenges and opened avenues for novel dietary strategies to enhance emotional resilience.

πŸ“š PublicationsΒ 

Stress-resilient Effect of Spirulina platensis on Zebrafish Chronic Unpredictable Stress Model

Authors: Kumar, H., Kaur, K., Kaur, R.

Journal: Physiology & Behavior

Year: 2024

Citations: 0

Role of Spirulina in Structural Remodeling of Synapse in Telencephalon of Chronic Unpredictable Stress Model of Zebrafish

Authors: Kumar, H., Garg, V., Kaur, K., Kaur, R.

Journal: Annals of Neurosciences

Year: 2023

Citations: 0

Synthesis of a Trinuclear Zinc(II) Cluster Composed of [4.4.3.01,5]Tridecane Cages: A Rapid Detection and Degradation Probe for the Chemical Warfare Agent Simulant Diethyl Cyanophosphonate in Protein-rich Food Products

Authors: Thakur, S., Rohilla, J., Kumar, K., Kumar, H., Singh, R., Kaur, V., Kamboj, R.

Journal: Analyst

Year: 2023

Citations: 4

ConclusionΒ 

Harender Kumar exhibits strong potential as a researcher in behavioral neuroscience, with impactful publications and an innovative focus on the gut-brain axis. While his current portfolio demonstrates high-quality research and interdisciplinary collaboration, there is room to enhance his profile by securing funded projects, expanding his professional engagement, and increasing the impact of his work through broader dissemination and applications. Overall, Harender is a commendable candidate for the Best Researcher Award, particularly for early-career recognition.

 

 

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

MD.,PhD at Β Medical University of Lublin , Poland

Dr. Ryszard Pluta is a distinguished neurologist and neuroscientist, with a medical degree from the Medical Academy in Lublin (1977) and a Ph.D. from the Polish Academy of Sciences (1983). He has served as a Professor at the Mossakowski Medical Research Institute and held prestigious postdoctoral fellowships at the NIH and NYS Institute for Basic Research. A recognized expert in brain ischemia and Alzheimer’s disease, Dr. Pluta has published extensively, including multiple influential books on the subject. He is a recipient of numerous awards and is an active member of several professional societies. His significant contributions to understanding the links between ischemia and Alzheimer’s have established him as a leading figure in neuropathology.

Profile:

ScopusΒ 

Education πŸŽ“

Ryszard Pluta earned his medical degree from the Medical Academy in Lublin (1971-1977) and attended Humboldt University in Berlin (1975) and the University of Cologne (1976). He completed his Ph.D. at the Polish Academy of Sciences in Warsaw (1983). He became an Associated Professor in 1992 and a full Professor in 2004 at the Mossakowski Medical Research Institute, Polish Academy of Sciences.

Work Experience πŸ’Ό

Dr. Pluta has held prestigious positions, including postdoctoral fellowships at the NIH in Bethesda, USA (1986-1988), and the NYS Institute for Basic Research in New York (1988-1989). He has been a Visiting Professor at several renowned institutions, including the Max-Planck Institute for Neurological Research and Charles University in Prague.

Skills 🧠

With extensive expertise in neuropathology and neurochemistry, Dr. Pluta specializes in brain ischemia and Alzheimer’s disease research. His skills encompass project management, collaboration with international research teams, and contributions to clinical studies in the field of neuroscience.

Awards and Honors πŸ†

Dr. Pluta has received numerous accolades, including recognition from the Polish Association of Neuropathologists (1980, 1986) and the Polish Academy of Sciences (1982, 1989, 1992). He was also honored by the International Brain Research Organization (1997) and the Alzheimer’s Association in Chicago (1998).

Membership 🀝

He is an active member of various professional organizations, including the Polish Association of Neuropathologists and the International Society of Neuropathology. Dr. Pluta is recognized among the World’s Top 2% scientists by Stanford University.

Teaching Experience πŸ“š

Dr. Pluta has contributed to the academic community through teaching positions at various universities, where he has shared his knowledge and expertise in neuropathology and neuroscience with students and researchers.

Research Focus πŸ”¬

His research focuses on brain ischemia, its relationship with Alzheimer’s disease, and associated neuropathological changes. He has made significant contributions, such as the documentation of identical changes in ischemic brains and those affected by Alzheimer’s, and the exploration of potential therapeutic approaches involving Ξ²-amyloid peptide.

 

Publications:

  • Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer’s Disease with Survival up to 2 Years
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Trans- and Cis-Phosphorylated Tau Protein: New Pieces of the Puzzle in the Development of Neurofibrillary Tangles in Post-Ischemic Brain Neurodegeneration of the Alzheimer’s Disease-like Type
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • A Look at the Etiology of Alzheimer’s Disease based on the Brain Ischemia Model
    • Year: 2024
    • Journal: Current Alzheimer Research
  • Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Ischemia-Reperfusion Programming of Alzheimer’s Disease-Related Genesβ€”A New Perspective on Brain Neurodegeneration after Cardiac Arrest
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2023
    • Journal: Cells
  • The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Preservation of Biomarkers Associated with Alzheimer’s Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
    • Year: 2023
    • Journal: Molecules
  • Post-Ischemic Permeability of the Blood–Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer’s Disease-Type Brain Neurodegeneration
    • Year: 2023
    • Journal: International Journal of Molecular Sciences

Dr NISHI PATEL | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr NISHI PATEL | Neuroscience | Best Researcher AwardΒ Β  πŸ†

Research Scholar at Bhagwan Mahavir University, Surat , IndiaπŸŽ“

Dr. Nishi Jayesh Patel is a dedicated research scholar at Bhagwan Mahavir University, specializing in the study of Parkinson’s Disease 🧠. With over four years of significant contributions in this field, she has become an expert in neurodegenerative disorders, particularly focusing on microbiology and probiotics. Dr. Patel has published research on the relationship between gut microflora and Parkinson’s, exploring innovative treatments such as in-vitro probiotic formulations. She is also a member of the Parkinson’s Foundation, continually striving to advance knowledge and treatment for the disease.

 

Professional ProfileΒ 

  • Google ScholarΒ 

Education πŸŽ“

Dr. Patel holds advanced degrees in microbiology and neurological sciences, fueling her passion for neurodegenerative disease research. Her academic excellence and thorough understanding of Parkinson’s Disease enable her to make meaningful strides in the field.

Work Experience 🏒

Apart from her research work, Dr. Patel is a seasoned subject matter expert and has contributed significantly to academic assessment by setting papers for national and international entrance exams. Her work in this area has helped shape the academic landscape and ensure high standards for future medical professionals.

Awards and Honors πŸ†

While specific awards are not mentioned, Dr. Patel’sΒ numerous professional contributions, including her membership in the Parkinson’s Foundation, speak to her dedication and excellence in the field of medical research.

Research Focus πŸ”

Dr. Patel’s core research focuses on probiotics and their role in neurological disorders. She has identified six bacterial strains that are potential candidates for therapeutic use in Parkinson’s Disease, with promising results in balancing GABA collapse, improving drug bioavailability, and controlling disease progression. These isolates show potential in controlling mood, immunity, and digestion, positively influencing patients’ well-being.

 

 

Publications :Β 

  • Evaluating Probiotic Properties of Gut Microflora for Gut Modulation as an Adjuvant Therapy for Parkinson’s Disease
    Authors: NJ Patel, M Hajoori
    Journal: Journal of Future Foods
    Year: 2025
    Volume: 5
    Issue: 3
    Pages: 304-316
  • Isolation, Characterisation, and Screening of Gut Bacteria for Essential Probiotic Characteristics
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: European Journal of Biomedical and Pharmaceutical Sciences
    Year: 2023
    Volume: 10
    Issue: 11
    Pages: 176-179
  • Comparative Formulation and Evaluation of Probiotic Products Utilizing Different Bacterial Strains: A Comprehensive Study
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Biological Forum – An International Journal
    Year: 2023
    Volume: 15
    Issue: 5
    Pages: 1747-1752
  • Psychobiotics: The Next Generation Adjuvant Therapy and Its Revolutionary Contribution in Treatment for Parkinson’s Disease
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Futuristic Trends in Medical Sciences
    Year: 2022
    Book: 21, Part 1
    Pages: 1-15
  • Bioremediation of Surfactants by Bacteria Isolated from Spume Used to Scavenge Surfactants Along with Dyes in Washing Textile Effluents
    Author: DRD Nishi Jayesh Patel
    Journal: JETIR Research Journal
    Year: 2020
    Volume: 7
    Issue: 6
    Pages: 1147-1153

 

Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Alexandros Kanellopoulos Neuroscience | Best ResearcherAwardΒ  πŸ†

Principal Scientist of Cognitive Health atΒ DSM-Firmenich, RD Innovation
SwitzerlandπŸŽ“

Alexandros Kanellopoulos is a seasoned Innovation Leader, Principal Scientist, and Clinical Director with over 20 years of expertise in Neuroscience, Metabolism, Early Life Nutrition (ELN), and Medical Nutrition. He has successfully led multidisciplinary teams, pioneered product innovations, and authored more than 20 high-impact publications. With 7 patents to his name, Alexandros excels in transforming scientific research into tangible solutions that meet market needs.

Professional ProfileΒ 

Education

Alexandros Kanellopoulos holds a Ph.D. in Neuroscience from Kapodistrian University, Greece (2008-2013), where his research focused on neurodevelopmental disorders. Prior to this, he completed his M.Sc. in Molecular Medicine (Neuroscience) at the same university (2005-2007), gaining advanced expertise in neuroscience and molecular biology. His academic foundation was established with a B.Sc. in Molecular Biology and Genetics from Dimocritus University of Thrace, Greece (2000-2005), where he developed a strong background in genetics and molecular biology.

Work Experience

In his current role as Global Principal Scientist & Clinical Director at DSM-Firmenich (2023-Present), Alexandros oversees scientific activities, driving innovation in dietary supplements and medical nutrition. Prior to this, he worked as an R&D Innovation Scientist and Project Manager at Nestle SA (2022-2023), leading the development of brain health products for Early Life Nutrition. In 2023, he also held the position of Medical, Scientific & Regulatory Affairs Manager at Nestle Nutrition, focusing on market communication and regulatory compliance. Alexandros previously served as Group Leader, Early Life Brain Metabolism at the University of Lausanne (2020-2022) and as Senior Scientist in Early Life Neuroscience (2016-2020), where he pioneered research in neurodevelopmental disorders.

SkillsΒ 

Alexandros is highly skilled in Innovation & Product Development, leading projects from concept to market. He is an expert in Clinical Research & Protocol Design, managing complex preclinical and clinical trials. His ability to lead multidisciplinary teams and drive Cross-functional Collaboration is complemented by his talent for Stakeholder Engagement & Market Alignment, ensuring alignment between research innovations and market needs. His Strategic Thinking, Problem-solving, and Emotional Intelligence are key to his success in high-impact research and business projects.

Awards & Honors

Throughout his career, Alexandros has earned more than 15 research awards, securing CHF 2.5 million in research funding. He has been awarded 7 patents as an inventor, reflecting his contributions to innovation in neuroscience and nutrition. In addition, he has delivered over 40 invited presentations at international conferences, establishing himself as a respected thought leader in his field.

Β MembershipΒ 

Alexandros contributes to the scientific community as a Reviewer for leading neuroscience journals and serves as an Editor in scientific publications, ensuring the dissemination of high-quality research.

Teaching Experience

Alexandros is also an experienced educator, having delivered lectures in Neuroscience and Medical Sciences at the University of Lausanne and Kapodistrian University, Athens. In his academic roles, he has mentored over 20 junior scientists, fostering the next generation of researchers and innovators.

Research Focus

Alexandros’ research centers on Early Life Nutrition and its role in brain development. He is particularly focused on Neurodevelopmental Disorders such as Autism and Fragile X Syndrome. His work on Brain Energy Metabolism and Mitochondrial Function provides insights into neurotransmission and social behavior. Alexandros has also designed Preclinical and Clinical Research aimed at developing nutritional solutions to address these complex medical challenges.

Publications :Β 

  • Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome
    🧠 International Journal of Molecular Sciences – 2024
    DOI: 10.3390/ijms25168787
  • Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits
    🧬 Cell – 2020
    DOI: 10.1016/j.cell.2020.02.044
  • Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
    πŸ”¬ The Journal of Neuroscience – 2020
    DOI: 10.1523/jneurosci.1846-19.2020
  • Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    🧩 Biological Psychiatry – 2019
    DOI: 10.1016/j.biopsych.2019.04.008
  • SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
    🧠 Neuron – 2019
    DOI: 10.1016/j.neuron.2019.05.002
  • Mitochondrial Dysfunction in Autism Spectrum Disorder: Clinical Features and Perspectives
    🧠 Current Opinion in Neurobiology – 2017
    DOI: 10.1016/j.conb.2017.05.018
  • Autism Spectrum Disorders: Translating Human Deficits into Mouse Behavior
    🐁 Neurobiology of Learning and Memory – 2015
    DOI: 10.1016/j.nlm.2015.07.013
  • Learning and Behavioral Deficits Associated with the Absence of the Fragile X Mental Retardation Protein: What a Fly and Mouse Model Can Teach Us
    🧠 Learning & Memory (Cold Spring Harbor, N.Y.) – 2014
    DOI: 10.1101/lm.035956.114
  • Learning and Memory Deficits Resulting from Reduction of the Fragile X Mental Retardation Protein: A Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila
    🧠 The Journal of Neuroscience – 2012
    DOI: 10.1523/JNEUROSCI.1347-12.2012
  • Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-blind, Placebo-controlled Study
    πŸ’Š The American Journal of Gastroenterology – 2011
    DOI: 10.1038/ajg.2011.179

Dr Andreu Massot TarrΓΊs | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Andreu Massot TarrΓΊs | Neuroscience | Best Researcher Award πŸ†

Neurologist at Hospital Universitari MΓΊtua Terrassa, SpainπŸŽ“

Andreu Massot TarrΓΊs, MD, PhD, is a highly accomplished neurologist and epileptologist with over 20 years of experience. He earned his Medical Doctorate from the Universitat AutΓ²noma de Barcelona in 2003 and later completed a PhD Cum Laude in Medicine, focusing on intracranial atherostenosis. He has held senior neurology positions at prestigious hospitals in Spain, including Hospital Universitari Vall d’Hebron, JimΓ©nez DΓ­az Foundation, and Hospital Universitari MΓΊtua Terrassa, where he currently serves. Dr. Massot TarrΓΊs has specialized expertise in epilepsy, EEG, and cerebrovascular diseases and has completed advanced fellowships in Canada and the UK.

Professional ProfileΒ 

Education

Andreu Massot TarrΓΊs earned his Medical Doctorate in August 2003 from the Universitat AutΓ²noma de Barcelona. He went on to complete his Neurology specialization in May 2009 at the Hospital Universitari Vall d’Hebron, Barcelona. In June 2013, he was awarded a PhD Cum Laude in Medicine by the same university for his thesis on intracranial atherostenosis, supervised by Dr. Montaner Villalonga and Dr. Álvarez-SabΓ­n. His commitment to epilepsy research led him to a Clinical and Research Fellowship in Epilepsy and EEG at Western University, Ontario, in 2014, followed by a Master in Epilepsy from the Universidad de Murcia in 2018, where he received an excellent qualification.

Β Work Experience

Dr. Massot TarrΓΊs’s medical career has spanned several prestigious institutions. Starting as a clinical observer in London (2008), he then became a Senior Neurologist in Barcelona and Madrid, working in the Neurovascular Unit at Vall d’Hebron (2009-2010) and the Epilepsy Unit at the JimΓ©nez DΓ­az Foundation (2010-2011). Between 2011 and 2021, he took on various senior roles, including at Hospital del Mar and Hospital Universitario Gregorio MaraΓ±Γ³n, Madrid. Since September 2021, he has been a Senior Neurologist and Epileptologist at Hospital Universitari MΓΊtua Terrassa, where he continues to excel in treating neurological disorders, particularly epilepsy.

Β SkillsΒ 

Dr. Massot TarrΓΊs is highly skilled in Electroencephalography (EEG) and Video-EEG monitoring. He has extensive experience in intraoperative electrocorticography, cortical stimulation mapping, and the Wada test. His expertise in cerebrovascular diseases and ultrasonography diagnostics has made him a leading lecturer at several top hospitals, including Vall d’Hebron, Hospital del Mar, and Hospital Gregorio MaraΓ±Γ³n.

Awards & Honors

He holds certifications in Electroencephalography from both the Canadian Society of Clinical Neurophysiology (2015) and the Spanish Society of Neurology (2016). He was also awarded a Cum Laude distinction for his doctoral work and has participated in advanced training like the NIH Stroke Scale Training by the National Stroke Association.

Β MembershipΒ 

Dr. Massot TarrΓΊs is an active member of the Spanish Society of Neurology and has contributed significantly to clinical neurophysiology through his memberships in various international medical bodies.

Β Teaching Experience

Dr. Massot TarrΓΊs has shared his knowledge extensively, offering lectures on epilepsy, neurovascular diseases, and ultrasonography techniques. He has taught at institutions like JimΓ©nez DΓ­az Foundation, Hospital del Mar, and Western University, where his work in EEG and cerebrovascular illness has helped shape the careers of future neurologists.

Β Research Focus

His research primarily focuses on epilepsy and ischemic cerebrovascular diseases. His PhD thesis, which examined markers of recurrence in intracranial atherostenosis, highlights his dedication to improving diagnostics and treatment outcomes in neurology. He continues to contribute to research on epilepsy and cerebrovascular conditions, aiming to reduce the recurrence of ischemic events in patients.

 

πŸ“–Publications :Β 

  • πŸ“„ “Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program”
    Author: Massot-TarrΓΊs, A.
    Journal: Epilepsia Open
    Year: 2023
    Volume: 8(3), pp. 918–929
  • πŸ“Š “Risk factors for comorbid epilepsy in patients with psychogenic non-epileptic seizures. Dataset of a large cohort study”
    Author: Massot-TarrΓΊs, A.
    Journal: Data in Brief
    Year: 2022
    Volume: 45, 108568
  • 🧠 “Roles of fMRI and Wada tests in the presurgical evaluation of language functions in temporal lobe epilepsy”
    Author: Massot-TarrΓΊs, A.
    Journal: Frontiers in Neurology
    Year: 2022
    Volume: 13, 884730
  • πŸ’Š “Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice”
    Co-author: Massot-TarrΓΊs, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108836
  • πŸ“ˆ “Factors associated with comorbid epilepsy in patients with psychogenic nonepileptic seizures: A large cohort study”
    Author: Massot-TarrΓΊs, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108780
  • 🧩 “Cortical myoclonus associated with coeliac disease showing a characteristic EEG pattern: A case report”
    Author: Massot-TarrΓΊs, A.
    Journal: Seizure
    Year: 2022
    Volume: 95, pp. 81–83
  • πŸš‘ “Response to anakinra in new-onset refractory status epilepticus: A clinical case”
    Author: Massot-TarrΓΊs, A.
    Journal: Seizure
    Year: 2022
    Volume: 94, pp. 92–94
  • 🦠 “Neurological complications of COVID-19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic”
    Co-author: Massot-TarrΓΊs, A.
    Journal: European Journal of Neurology
    Year: 2021
    Volume: 28(10), pp. 3339–3347
  • πŸ“‰ “Predicting outcome of patients with psychogenic nonepileptic seizures after diagnosis in an epilepsy monitoring unit”
    Author: Massot-TarrΓΊs, A.
    Journal: Epilepsy and Behavior
    Year: 2021
    Volume: 120, 108004
  • 🧬 “E200K familial Creutzfeldt-Jakob disease. MRI, EEG, PET and neuropathological correlation in a family”
    Co-author: Massot-TarrΓΊs, A.
    Journal: Neurologia
    Year: 2021
    Volume: 36(5), pp. 399–401

 

Hussein Al-Hakeim | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Hussein Al-Hakeim | Neuroscience | Best Researcher Award πŸ†

Peofessor of Medical Biochemistry at University of Kufa, IraqπŸŽ“

Β Professor Dr. Hussein Kadhem Al-Hakeim is a distinguished Iraqi academic specializing in Medical Biochemistry, Biological Psychiatry, Insulin Resistance, and Nanobiochemistry. Residing at 28 Al-Adala, Najaf, Iraq, he is currently affiliated with Kufa University. Dr. Al-Hakeim is well-recognized for his significant contributions to biochemistry and clinical chemistry in Iraq.

Professional ProfileΒ 

EducationπŸŽ“

Dr. Al-Hakeim earned his B.Sc. in Chemistry from the University of Mosul in 1991, followed by an M.Sc. in Medical Chemistry and a High Graduate Diploma in Clinical Biochemistry from Al-Nahrain University in 2000 and 2001, respectively. He completed his Ph.D. in Medical Chemistry at the same institution in 2004. Additionally, he holds a Diploma in International Law and Diplomatic Relations from Cairo Regional Center for Training and Arbitration, obtained in 2017.

Β πŸ’ΌWork Experience

Dr. Al-Hakeim has held various leadership roles, including Head of the Department of Chemistry at Kufa University and the University of Karbala. He has served as the Assistant Dean and Chief of the Examination Committee at the College of Science, University of Karbala. His teaching career includes extensive experience as a lecturer in postgraduate studies across multiple universities in Iraq.

Β πŸ› οΈSkills

Dr. Al-Hakeim is an expert in Medical and Clinical Biochemistry, Nanobiochemistry, Insulin Resistance, and Stem Cell Technology. He has a profound knowledge of biostatistics, biosensors, and protein-nanoparticle interactions, and is skilled in advanced laboratory techniques and various biochemical analysis methods.

Β πŸ†Awards and Honors

Dr. Al-Hakeim’s work has been recognized at numerous scientific congresses and conferences worldwide. His research contributions and academic leadership have earned him a prominent place in Iraq’s scientific community.

Β Membership πŸ›οΈand Affiliations 🀝

Dr. Al-Hakeim is an active member of several scientific committees and associations. He frequently participates in international conferences and has presented his research at numerous prestigious events.

Β Teaching ExperienceπŸ‘¨β€πŸ«

Dr. Al-Hakeim has taught a wide range of courses at the B.Sc., M.Sc., and Ph.D. levels. His subjects include Advanced Biochemistry, Clinical Biochemistry, Toxicology, Endocrinology, Biostatistics, and more. He has also coordinated several courses and training programs, contributing significantly to the academic development of his students.

Β Research Focus πŸ”¬

Dr. Al-Hakeim’s research interests encompass Medical Biochemistry, Clinical Chemistry, Insulin Resistance Mechanisms, Stem Cell Technology, Nanobiochemistry, and the Medical Applications of Surface Chemistry. His work is particularly focused on protein-nanoparticle interactions, a field where he has made substantial contributions.

πŸ“–Publications :Β 

  • IL-6, IL-18, sIL-2R, and TNFΞ± proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation
    • πŸ—“οΈ Year: 2015
    • πŸ“š Journal: Journal of Affective Disorders
  • Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses, and inflammation: a proof of concept
    • πŸ—“οΈ Year: 2023
    • πŸ“š Journal: Molecular Psychiatry
  • Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients
    • πŸ—“οΈ Year: 2011
    • πŸ“š Journal: Asian Journal of Transfusion Science
  • Intersections between pneumonia, lowered oxygen saturation percentage, and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID
    • πŸ—“οΈ Year: 2021
    • πŸ“š Journal: Journal of Affective Disorders
  • The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
    • πŸ—“οΈ Year: 2022
    • πŸ“š Journal: Molecular Psychiatry
  • The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis
    • πŸ—“οΈ Year: 2022
    • πŸ“š Journal: medRxiv
  • Serum levels of lipids, calcium, and magnesium in women with hypothyroidism and cardiovascular diseases
    • πŸ—“οΈ Year: 2009
    • πŸ“š Journal: Journal of Laboratory Physicians
  • High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and…
    • πŸ—“οΈ Year: 2020
    • πŸ“š Journal: Schizophrenia Bulletin
  • IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder
    • πŸ—“οΈ Year: 2019
    • πŸ“š Journal: European Psychiatry
  • Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision…
    • πŸ—“οΈ Year: 2023
    • πŸ“š Journal: Acta Neuropsychiatrica
  • The physio-affective phenome of major depression is strongly associated with biomarkers of astroglial and neuronal projection toxicity which in turn are associated with…
    • πŸ—“οΈ Year: 2023
    • πŸ“š Journal: Journal of Affective Disorders
  • Serum interleukin levels and insulin resistance in major depressive disorder
    • πŸ—“οΈ Year: 2018
    • πŸ“š Journal: CNS & Neurological Disorders – Drug Targets
  • Lowered quality of life in long COVID is predicted by affective symptoms, chronic fatigue syndrome, inflammation, and neuroimmunotoxic pathways
    • πŸ—“οΈ Year: 2022
    • πŸ“š Journal: International Journal of Environmental Research and Public Health
  • Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity…
    • πŸ—“οΈ Year: 2020
    • πŸ“š Journal: CNS Spectrums
  • The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
    • πŸ—“οΈ Year: 2022
    • πŸ“š Journal: Brain, Behavior, & Immunity – Health
  • The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study
    • πŸ—“οΈ Year: 2020
    • πŸ“š Journal: Neurotoxicity Research
  • Serum apelin and galectin-3 in preeclampsia in Iraq
    • πŸ—“οΈ Year: 2020
    • πŸ“š Journal: Hypertension in Pregnancy
  • Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia
    • πŸ—“οΈ Year: 2020
    • πŸ“š Journal: Current Topics in Medicinal Chemistry
  • Estimation of Serum Copper, Manganese, Selenium, and Zinc in Hypothyroidism Patients
    • πŸ—“οΈ Year: 2009
    • πŸ“š Journal: IUFS Journal of Biology
  • Major depression in children with transfusion-dependent thalassemia is strongly associated with the combined effects of blood transfusion rate, iron overload, and increased pro…
    • πŸ—“οΈ Year: 2020
    • πŸ“š Journal: Neurotoxicity Research

Marjan Shariatpanahi | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Marjan Shariatpanahi | Β Neuroscience | Best Researcher AwardΒ 

Associate professor at Iran university of medical sciences,Iran

Dr. Marjan Shariatpanahi is an Associate Professor in the Department of Pharmacology and Toxicology at the School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran. With extensive experience in toxicology and pharmacology, Dr. Shariatpanahi has made significant contributions to research on neurodegenerative diseases and toxicology.

professional profile

scopus

google scholar

Education πŸŽ“

Dr. Shariatpanahi holds a Doctor of Pharmacy (Pharm. D.) from Islamic Azad University, Tehran (2000-2006) with a thesis on thymidine phosphorylase and estrogen receptor alpha in colorectal cancer. She also earned a Ph.D. in Toxicology from Tehran University of Medical Sciences (2009-2014), focusing on the effects of PKG on spatial memory deficits and markers of autophagy and apoptosis in rats.

Work Experience πŸ₯

Dr. Shariatpanahi has a diverse professional background. She has been the Head of the Pharmacology & Toxicology Department at Iran University of Medical Sciences since 2017. Her previous roles include Dean of the Educational Office (2020-2023), Head of Student and Cultural Affairs (2019-2020), and faculty member at the Neuroscience Research Center (2018-present). She has also worked as an Assistant Professor at both Iran University of Medical Sciences and Guilan University of Medical Sciences, and as a Responsible Pharmacist in various institutions.

Skills πŸ› οΈ

Dr. Shariatpanahi is proficient in various research techniques, including IHC, Western blot, ICC, in vivo studies, and behavioral tests for neurodegenerative diseases. Her expertise extends to TLC, spectrophotometry, SPSS, PRISM, ELISA, and gas chromatography. She is also skilled in using atomic absorption machines and Endnote.

Awards and Honors πŸ…

Dr. Shariatpanahi has received several accolades, including being named the best professor at the Vosough Festival of IUMS (2023) and being recognized as a selected pharmacist (2022). She was also acknowledged as a top student in toxicology and pharmacy, receiving first ranks in board examinations and seminars.

Professional Memberships πŸ”—

Dr. Shariatpanahi is a member of the Iranian Association of Toxicology, the Iranian Medical Council, the Iranian Association of Pharmacists, the Iranian Probiotics Society, and the Talent Society of Tehran University.

Teaching Experience πŸ“š

Dr. Shariatpanahi has taught a wide range of courses across various levels. For Ph.D. students, she covers basics of pharmacology. For Doctor of Pharmacy students, she teaches toxicology, pharmacology, clinical toxicology, and specialized pharmacy language. Her M.Sc. teaching includes environmental toxicology, forensic toxicology, and advanced research methods, while for B.Sc. students, she focuses on toxicology.

Research Focus πŸ”¬

Dr. Shariatpanahi’s research interests include neuroscience, with a focus on autism, Alzheimer’s disease, memory, and Parkinson’s disease. She is also involved in toxicology, environmental toxicology, pharmacology, cell signaling, stem cell therapy, and the study of behavioral investigations on animals. Her work explores various markers and mechanisms in carcinogenesis, angiogenesis, and the protective and toxic effects of nanoparticles.

Conclusion

Dr. Marjan Shariatpanahi’s extensive qualifications, leadership roles, significant research contributions, and recognition in the field make him an excellent candidate for the Best Researcher Award. His achievements demonstrate a strong commitment to advancing knowledge in pharmacology and toxicology, contributing valuable insights into neurodegenerative diseases, toxicology, and pharmacology.

publicationΒ 

 

Lianyan Huang | Neuroscience | Best Researcher Award

Posted on by sciencefather

Β Prof Lianyan Huang | Neuroscience | Best Researcher Award

professor / Ph.D. advisor at Sun-yat sen university Guangzhou, China

Dr. Lianyan Huang is a professor at Zhongshan School of Medicine, Sun Yat-sen University, with expertise in neuroscience. She completed her postdoctoral training at NYU and has received numerous honors, including the Guangdong Provincial Award. Her research focuses on neural coding mechanisms and neurological disorders, with key findings published in top journals. πŸ§ πŸ“šπŸ†

professional profile :

Awards and Honors

10th SCBA Meeting Scholarship (2004) πŸ…Excellent Postgraduate Scholarships of Guangdong Province (2006, 2009) πŸŽ“Academician Scholarship of Southern Medical University (2006) πŸ†Guangdong Provincial Award for Outstanding Young and Middle-Aged Clinical Medical Teachers (2023) πŸ†

Professional Work Experience

Professor and Ph.D. Advisor, Zhongshan School of Medicine, Sun Yat-sen University (2017-present) πŸ‘©β€πŸ«Postdoctoral Fellow, NYU School of Medicine (2012-2017) 🧠Faculty and Lecturer, Southern Medical University (2008-2011) πŸ‘©β€πŸ«Graduate Research Assistant, The First Military Medical University (2003-2006) πŸ‘©β€πŸ”¬

Skills

Neuroscience Research 🧠Clinical Medicine 🩺Cell Biology πŸ”¬Teaching and Advising πŸŽ“Leadership in Professional Committees πŸ‘©β€πŸ«

Other Experience and Professional Memberships

  • 2006-present: Member, Society for Neuroscience of China πŸ§ πŸ”¬

publication:

Pain experience reduces social avoidance to others in pain: a c-Fos-based functional connectivity network study in mice

πŸ“… 2024 πŸ“° Cerebral Cortex 🧠

Authors: Li, J., Qin, Y., Zhong, Z., Huang, L., Li, B.

Sexually dimorphic control of affective state processing and empathic behaviors

πŸ“… 2024 πŸ“° Neuron 🧠

Authors: Fang, S., Luo, Z., Wei, Z., Huang, L., Li, B.

An insular cortical circuit required for itch sensation and aversion

πŸ“… 2024 πŸ“° Current Biology 🧬

Authors: Zheng, J., Zhang, X.M., Tang, W., Huang, L., Li, B.

EF1Ξ±-associated protein complexes affect dendritic spine plasticity by regulating microglial phagocytosis in Fmr1 knock-out mice

πŸ“… 2024 πŸ“° Molecular Psychiatry 🧠

Authors: Su, P., Yan, S., Chen, K., Yang, G., Liu, F.

Differences in the neural basis and transcriptomic patterns in acute and persistent pain-related anxiety-like behaviors

πŸ“… 2023 πŸ“° Frontiers in Molecular Neuroscience 🧬

Authors: Fang, S., Qin, Y., Yang, S., Li, B., Huang, L.

Distinct behavioral traits and associated brain regions in mouse models for obsessive–compulsive disorder

πŸ“… 2021 πŸ“° Behavioral and Brain Functions 🧠

Authors: Chen, X., Yue, J., Luo, Y., Li, B., Wen, S.

Enriched Environment Prevents Surgery-Induced Persistent Neural Inhibition and Cognitive Dysfunction

πŸ“… 2021 πŸ“° Frontiers in Aging Neuroscience 🧬

Authors: Yang, S., Zhang, S., Tang, W., Huang, L., Li, B.

BDNF produced by cerebral microglia promotes cortical plasticity and pain hypersensitivity after peripheral nerve injury

πŸ“… 2021 πŸ“° PLoS Biology πŸ”¬

Authors: Huangi, L., Jin, J., Chen, K., Gan, W.-B., Yang, G.

Learning-dependent dendritic spine plasticity is impaired in spontaneous autoimmune encephalomyelitis

πŸ“… 2021 πŸ“° Developmental Neurobiology 🧠

Authors: Huang, L., Lafaille, J.J., Yang, G.

Learning-Dependent Dendritic Spine Plasticity Is Reduced in the Aged Mouse Cortex

πŸ“… 2020 πŸ“° Frontiers in Neural Circuits 🧬

Authors: Huang, L., Zhou, H., Chen, K., Chen, X., Yang, G.

 

 

Amit Chougule | Cognitive Neuroscience | Best Researcher Award

Posted on by sciencefather

Mr Amit Chougule | Cognitive Neuroscience | Best Researcher Award

 

Researcher atΒ Manentia AI, India

 

 

πŸ“š Amit Chougule is a distinguished deep learning and AI researcher with a PhD from BITS Pilani, dedicated to advancing AI through cutting-edge research, algorithm development, and impactful industry contributions. He has over 3 years of expertise in AI and Computer Vision, having worked with esteemed organizations like Philips Research, Sony Research India, and Carleton University’s TrustCAV Research. Amit is proficient in Python and skilled in utilizing various libraries for data manipulation, statistical analysis, and machine learning. His experience includes designing end-to-end AI solutions and developing models for healthcare, autonomous vehicles, and more. πŸš€πŸ€–πŸ“Š

Professional Profile:

 

πŸŽ“ Education:

  • PhD in Computer Vision & AI, BITS Pilani, Pilani (2021-2024)
    • Thesis: Artificial Intelligence Enabled Vehicular Vision and Service Provisioning for Advanced Driver Assistance Systems (ADAS)
    • Supervisors: Dr. Vinay Chamola, Dr. Pratik Narang & Prof. F. Richard Yu (IEEE Fellow)
  • M.Tech in Big Data & IoT, PES University, Bengaluru (2018-2020)
    • Specializations: IoT, Cloud Computing, Big Data & Cyber Security
  • B.Tech in Computer Engineering, Shivaji University (2013-2017)
    • Focus Areas: Computer Algorithm, Data Structure, Computer Networks & Operating System

πŸ’Ό Experience:

  • Visiting Researcher, Carleton University, Canada (Dec 2022 – June 2023)
    • Developed techniques for enhancing self-driving vehicles.
    • Analyzed the impact of abnormal weather on vision-based autonomous vehicle operations.
    • Introduced a computer vision-based attention model for reliable autonomous driving in adverse weather.
  • Computer Vision Intern (PhD), Sony Research (Oct 2022 – Nov 2022)
    • Innovated a computer vision model for diagnosing diseases using biomarkers.
    • Developed an advanced pipeline for predicting diseases based on anatomical biomarkers.
  • Machine Learning Engineer, AIvolved Technologies (Aug 2020 – Dec 2020)
    • Worked on object detection, tracking, pose estimation, and web scraping for applications like gait analysis and traffic analysis.
  • Computer Vision Intern, Philips Healthcare Research (July 2019 – July 2020)
    • Conducted research on ultrasound medical imaging.
    • Developed an Anatomical Intelligent Fetal Heart Ultrasound Scanning technique.
    • Implemented an AI model for precise estimation of fetal femur length.

πŸ”§ Skills:

  • Programming Languages: C, C++, JAVA, Python, SQL
  • Machine Learning Frameworks: PyTorch, Keras, TensorFlow
  • CI/CD Tools: Git
  • MLOps Frameworks and Tools: Docker, Kubernetes
  • Data Pipelines and Analytics Tools: Apache Spark, PySpark
  • Image Processing: OpenCV, Matplotlib, Scikit-image, SciPy, Pillow
  • Generative AI: Autoencoders, GANs, Diffusion Models
  • Computer Vision Domains: Image Classification, Object Detection, Object Tracking, Segmentation, Pose Estimation, Computational Geometry, Image Generation
  • Medical Imaging Tools: ImageJ, 3D Slicer, OsiriX, SimpleITK, ITK-SNAP, RadiAnt DICOM
  • Hardware: Arduino, Raspberry Pi, Nvidia Jetson Nano

πŸ† Awards and Honors:

  1. Generative Adversarial Networks (GANs) Specialization by Coursera
  2. Deep Learning with Numpy by Udemy
  3. Getting Started with AWS Machine Learning by Amazon (Coursera)
  4. Computer Vision Basics by University at Buffalo and The State University of New York (Coursera)
  5. Digital Image Processing with OpenCV in Python by GEO University
  6. Data Science with Python by Pluralsight
  7. Pandas Foundations by Datacamp
  8. Python (Advanced Level) by HackerRank

πŸ”¬ Research Focus:

Amit Chougule is dedicated to advancing artificial intelligence through cutting-edge research, innovative algorithm development, and impactful industry contributions. He focuses on:

  • Deep Learning Technology: Solving complex real-world problems and driving societal impact.
  • Computer Vision: Enhancing autonomous vehicle capabilities, especially in adverse weather conditions.
  • Medical Imaging: Developing AI models for accurate disease diagnosis and fetal growth prediction.
  • AI Solutions: Designing end-to-end AI solutions, from data pipeline architecture to model deployment.

Publications:Β